#PharmD #clinicalpharmacy #Drugupdate #Obesitymanagement To view or add a comment, sign in Obesity Market is Expected to Witness Significant Growth by 2036 Due to Advancements in GLP-1 Therapies and Expanding Treatment Accessibility | DelveInsight: The obesity market is experiencing substantial transformation driven by the rising global obesity burden, growing awareness regarding obesity as a chronic disease, increasing adoption of GLP-1 receptor agonists, and the emergence of next-generation metabolic therapies
The peer-reviewed literature is indexed on PubMed
Rights and permissions About this article Cite this article Estaras, M., Moreno, N., Santofimia-Castao, P
Using fat for energy can help you sustain long-duration workouts
Biol Pharm Bull 42:16891693 Rifaioglu MM, Davarci M, Nacar A, Alp H, Celik M, Sefil NK, Inci M (2014) Caffeic acid phenethyl ester (CAPE) protects against acute urogenital injury following pneumoperitoneum in the rat